Login / Signup

Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial.

Sae IshimaruTatsunori ShimoiKuniko SunamiMiho NakajimaYayoi AndoNatsuko OkitaKenichi NakamuraTaro ShibataYasuhiro FujiwaraNoboru Yamamoto
Published in: International journal of clinical oncology (2023)
The BELIEVE trial provides hope for patients with actionable genetic abnormalities by facilitating access to targeted therapies through off-label drug administration. It establishes a regulatory framework and promotes collaboration between industry and academia by expanding organ-specific and cross-organ biomarker-based treatments.
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • drug administration
  • healthcare
  • randomized controlled trial
  • palliative care
  • copy number
  • mental health
  • open label
  • gene expression
  • electronic health record